Butterfly iQ3 Ultrasound System vs Global Hypoperfusion Index (GHI) Algorithm

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Butterfly Network
VS
by Edwards Lifesciences

AI Verdict

These tools are adjacent in their application within critical care and emergency medicine, both offering AI-powered clinical decision support. However, the Butterfly iQ3 is a diagnostic imaging system providing real-time ultrasound, while the Global Hypoperfusion Index Algorithm is a predictive analytics tool for hemodynamic instability. Clinicians would choose the Butterfly iQ3 for point-of-care imaging and diagnosis, whereas the GHI Algorithm would be selected for proactive risk assessment of hypoperfusion events.

Choose Butterfly iQ3 Ultrasound System if…

Choose the Butterfly iQ3 Ultrasound System if you require a versatile, portable, whole-body imaging solution at the point of care. Its single probe and AI-powered tools are ideal for rapid diagnostics and streamlined workflows in emergency medicine, critical care, or any setting where immediate visual assessment is crucial for a wide range of clinical applications.

View Butterfly iQ3 Ultrasound System →

Choose Global Hypoperfusion Index (GHI) Algorithm if…

Choose the Global Hypoperfusion Index (GHI) Algorithm if your primary need is proactive prediction of hypoperfusion events in critical care settings. This AI tool provides early warnings (10-15 minutes in advance) based on real-time patient data, enabling clinicians to intervene promptly and potentially prevent adverse outcomes in patients monitored with compatible advanced hemodynamic platforms.

View Global Hypoperfusion Index (GHI) Algorithm →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Butterfly iQ3 Ultrasound System Global Hypoperfusion Index (GHI) Algorithm
Pricing Paid, subscription required Contact for pricing
Deployment Mobile app (iOS/Android) to Butterfly Cloud, with DICOM connector for EMR/PACS integration. Integrated into compatible advanced hemodynamic monitoring platforms, such as the HemoSphere Alta™ Advanced Monitoring Platform.
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Butterfly iQ3 Ultrasound System

Butterfly iQ3 offers a highly portable, handheld device with a user-friendly mobile app interface, making it accessible at the point of care. Its single probe for multiple applications and compatibility with common mobile devices enhance its ease of use in diverse clinical settings.

Clinical Value

Butterfly iQ3 Ultrasound System

Butterfly iQ3 provides immediate, real-time whole-body ultrasound imaging with AI-powered tools for enhanced diagnostic confidence across over 20 clinical applications. This broad utility directly supports quicker diagnoses and streamlined workflows at the point of care.

Pricing & Value

Butterfly iQ3 Ultrasound System

Butterfly iQ3 has transparent pricing for both the probe and a required annual software subscription, allowing for clear cost assessment. While an investment, its versatility across numerous applications and specialties offers significant value for money.

Enterprise Readiness

Butterfly iQ3 Ultrasound System

Butterfly iQ3 is designed for enterprise integration, offering HIPAA compliance, FDA clearance, and a DICOM connector for EMR/PACS integration. Its deployment via mobile app to Butterfly Cloud provides a scalable solution for healthcare systems.

Innovation

Butterfly iQ3 Ultrasound System

Butterfly iQ3 showcases significant innovation with its Ultrasound-on-Chipu2122 technology, offering whole-body imaging from a single probe. Its suite of AI-powered imaging tools like iQ Sliceu2122 and Auto B-Line Counter represents cutting-edge advancements in portable ultrasound.

Support & Docs

Tie

Both tools are from reputable companies in the healthcare space, suggesting a high standard of support and documentation. However, without specific details on the breadth and depth of their support services or documentation, it's difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Butterfly iQ3 Ultrasound System Global Hypoperfusion Index (GHI) Algorithm
Name Butterfly iQ3 Ultrasound System Global Hypoperfusion Index (GHI) Algorithm
Company Butterfly Network Edwards Lifesciences
Description The Butterfly iQ3 is a handheld, whole-body ultrasound system featuring advanced Ultrasound-on-Chipu2122 technology, AI-powered tools, and seamless mobile integration for enhanced diagnostic confidence and streamlined workflows at the point of care. The Global Hypoperfusion Index (GHI) Algorithm by Edwards Lifesciences is an FDA-cleared AI tool that predicts the likelihood of global hypoperfusion events 10-15 minutes in advance, providing critical insights for proactive patient management in critical care settings.
Categories Clinical Decision Support & Reference, Radiology & Imaging AI Clinical Decision Support & Reference, Triage & ER/ICU AI
Specialties Critical Care, Emergency Medicine, Radiology Anesthesiology, Critical Care, Emergency Medicine
Key Features (Examples) Ultrasound-on-Chipu2122 technology for whole-body imaging, Single probe for 20+ clinical applications (1-12 MHz frequency), AI-powered imaging tools: iQ Sliceu2122, iQ Fanu2122, Auto Bladder Volume, Auto B-Line Counter, NeedleVizu2122 Predicts global hypoperfusion events 10-15 minutes in advance, Generates an index (0-100) indicating the likelihood of an event, Utilizes a machine-learning model based on real-time patient health data

Videos

Demos, reviews, and walkthroughs featuring Butterfly iQ3 Ultrasound System and Global Hypoperfusion Index (GHI) Algorithm.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Butterfly iQ3 is a handheld ultrasound system that integrates with a mobile app and Butterfly Cloud, offering a DICOM connector for EMR/PACS integration. It can streamline workflows by automating documentation at the point of scan, reducing administrative burden and supporting accurate billing. The Global Hypoperfusion Index (GHI) Algorithm is integrated into compatible advanced hemodynamic monitoring platforms, such as the HemoSphere Altau2122 Advanced Monitoring Platform, to provide real-time insights for proactive patient management in critical care settings.
The Butterfly iQ3 offers enhanced image quality, resolution, sensitivity, and penetration due to its advanced semiconductor chip and faster processing power. It also features AI-powered tools like iQ Sliceu2122 and iQ Fanu2122 for improved image capture and analysis. The GHI Algorithm predicts global hypoperfusion events 10-15 minutes in advance, generating an index from 0-100 based on real-time patient health data. While specific accuracy and sensitivity metrics for the GHI are not provided in the description, similar hypoperfusion index algorithms in stroke prediction have shown sensitivities ranging from 68.7% to 100% and specificities from 61% to 92.7% in various studies.
The Butterfly iQ3 is designed for ease of use with a user-friendly ergonomic design and integrated user education, including a 360u00b0 education suite and an educational app called Butterfly ScanLabu2122. Butterfly also offers an Education Portal with tutorials taught by ultrasound experts. The GHI Algorithm is intended for use by qualified personnel or trained clinicians in a critical care environment, suggesting a need for familiarity with advanced hemodynamic monitoring, but specific learning curve details or dedicated training programs are not described.
The Butterfly iQ3's cloud-based platform manages and archives studies, which is critical for CPT reimbursement and maintaining a legal 'paper trail' during audits. While not explicitly detailed as an 'audit trail' feature, the system's ability to connect to the EHR and save scans, regardless of the machine brand, suggests a mechanism for tracking and accountability. The GHI Algorithm's description does not specify audit-trail features, but generally, audit trails in clinical imaging are secure, time-stamped electronic records of all actions performed on data, capturing who did what, to which file, and when.
The Butterfly iQ3, being a handheld and portable device with cloud-based centralized storage and EMR integration, is well-suited for multi-site deployment, enhancing diagnostic workflows and collaboration across departments. Its software platform, Compass AIu2122, can also help manage ultrasound programs across different machines and departments. The GHI Algorithm's deployment is integrated into compatible advanced hemodynamic monitoring platforms, implying that multi-site rollout would depend on the existing infrastructure and standardization of these platforms across sites.
The Butterfly iQ3 is highly beneficial for point-of-care ultrasound across numerous specialties, including critical care, emergency medicine, radiology, anesthesiology, and OB/GYN, enabling rapid bedside assessments for conditions like internal bleeding, cardiac function, lung conditions, DVT, and guiding procedures like nerve blocks. The GHI Algorithm is specifically designed for critical care and emergency medicine settings to predict global hypoperfusion events 10-15 minutes in advance, aiding in proactive patient management and anticipating hemodynamic instability in surgical and non-surgical patients receiving advanced hemodynamic monitoring with a Swan-Ganz catheter.
AI Tool Finder
AI-powered search. Results may not be comprehensive.